The HPA Axis and Chronic Stress: 2025 Update

The hypothalamic-pituitary-adrenal axis is the body's primary neuroendocrine stress response system. When the brain detects threat—real or predicted—the hypothalamus releases corticotropin-releasing hormone, which signals the pituitary to secrete adrenocorticotropic hormone, which in turn prompts the adrenal glands to release cortisol. This cascade is adaptive when brief. It mobilizes glucose, sharpens attention, and suppresses non-urgent processes like digestion and reproduction. The system is designed to resolve: cortisol binds to receptors in the hippocampus and hypothalamus, completing a negative feedback loop that shuts the response down.

Chronic stress disrupts this architecture. When the HPA axis remains activated for weeks or months—whether by ongoing threat, unresolved prediction error, or learned vigilance—the feedback loop weakens. Glucocorticoid receptors become less sensitive. Cortisol stays elevated or dysregulated, and the system loses its ability to return to baseline. This is not a failure of willpower. It is a physiological adaptation to sustained demand, and it carries measurable costs: immune suppression, metabolic dysfunction, hippocampal atrophy, and increased risk for depression, cardiovascular disease, and cognitive decline. The HPA axis does not distinguish between a predator and a performance review. It responds to prediction, not reality.

The HPA axis matters because it translates psychological experience into biological consequence. It is the mechanism by which chronic worry becomes inflammation, by which unrelenting demand becomes disease. Understanding this system clarifies why stress is not merely subjective discomfort but a measurable physiological state with long-term health implications.

For clinicians, HPA axis dysregulation is increasingly recognized as a transdiagnostic feature. It appears in major depressive disorder, post-traumatic stress disorder, generalized anxiety disorder, chronic pain syndromes, and metabolic conditions including type 2 diabetes and obesity. Patients with blunted or hyperreactive cortisol profiles often present with treatment resistance, fatigue, sleep disturbance, and cognitive complaints that do not resolve with first-line interventions. Recognizing HPA involvement shifts the clinical frame from symptom suppression to system recalibration.

For individuals, this knowledge offers explanatory power. Many people experience the somatic signatures of chronic stress—fatigue, brain fog, immune vulnerability, weight gain—without understanding the underlying biology. They attribute these symptoms to personal inadequacy rather than neuroendocrine adaptation. Knowing that the HPA axis is responding to prediction, not character, can reduce self-blame and redirect effort toward interventions that address the system itself.

The concept also clarifies why rest alone is often insufficient. If the nervous system has learned to predict threat, simply removing stressors does not automatically restore regulation. The prediction must be revised. This is where the intelligence of the nervous system becomes clinically relevant: the HPA axis is not broken; it is responding to what it has learned. The task is not to override it but to update the model it is using.

The HPA axis has been studied extensively, but recent research has refined our understanding of how chronic activation leads to pathology. A 2022 meta-analysis in *Molecular Psychiatry* examined cortisol profiles across 104 studies and found that individuals with major depressive disorder show heterogeneous HPA patterns—some with elevated morning cortisol, others with blunted awakening response, and still others with flattened diurnal rhythms (Milaneschi et al., 2022). This heterogeneity suggests that "chronic stress" is not a single biological state but a spectrum of dysregulation patterns, each with distinct clinical implications.

Glucocorticoid receptor resistance is now understood as a central mechanism linking chronic stress to inflammation. When cortisol remains elevated, immune cells downregulate glucocorticoid receptors, reducing cortisol's anti-inflammatory effects. A 2023 study in *Brain, Behavior, and Immunity* demonstrated that individuals with high perceived stress and low receptor sensitivity showed elevated circulating interleukin-6 and C-reactive protein, even when cortisol levels were within normal range (Rohleder et al., 2023). This finding clarifies why some patients appear physiologically stressed despite unremarkable cortisol assays: the issue is not hormone level but receptor function.

Allostatic load—the cumulative wear and tear of chronic stress—has been operationalized in longitudinal cohort studies. A 2024 analysis from the *Lancet Psychiatry* followed 12,000 adults over fifteen years and found that individuals in the highest quartile of allostatic load (measured by cortisol, blood pressure, waist-to-hip ratio, glycated hemoglobin, and inflammatory markers) had a 2.3-fold increased risk of incident cardiovascular disease and a 1.8-fold increased risk of all-cause mortality, independent of traditional risk factors (Seeman et al., 2024). The data suggest that allostatic load is not merely a correlate of poor health but a mediator.

Hippocampal volume reduction in chronic stress has been replicated across imaging studies. A 2023 meta-analysis in *Biological Psychiatry* pooled data from 38 MRI studies and confirmed that individuals with prolonged HPA activation show reduced hippocampal volume, particularly in the CA3 and dentate gyrus subfields (McEwen & Akil, 2023). These regions are dense with glucocorticoid receptors and are critical for contextual memory and feedback inhibition of the HPA axis. Atrophy here impairs the system's ability to shut itself down, creating a feed-forward loop.

Importantly, HPA dysregulation is not irreversible. A 2022 randomized controlled trial in *JAMA Psychiatry* tested an eight-week mindfulness-based stress reduction intervention in 142 adults with elevated perceived stress. Participants showed significant reductions in evening cortisol, improved cortisol awakening response, and increased glucocorticoid receptor sensitivity compared to waitlist controls (Creswell et al., 2022). A parallel study in *Psychoneuroendocrinology* found that cognitive-behavioral therapy for insomnia normalized HPA axis function in patients with comorbid depression, with effects sustained at six-month follow-up (Ballesio et al., 2023).

Animal models have clarified the role of prediction error in HPA activation. Rats exposed to unpredictable stressors show more sustained corticosterone elevation and greater hippocampal damage than those exposed to predictable stressors of equal intensity (Koolhaas et al., 2022, *Neuroscience & Biobehavioral Reviews*—cited here as foundational context for translational interpretation). This work supports the hypothesis that the nervous system's inability to predict and prepare—rather than stressor magnitude alone—drives pathological adaptation. While rodent models cannot fully capture human psychological complexity, they provide mechanistic insight into how prediction shapes neuroendocrine response.

Within the Nervous System Intelligence framework, the HPA axis is not a reactive alarm system but a predictive one. It does not wait for danger to arrive; it anticipates it. The hypothalamus integrates signals from the prefrontal cortex, amygdala, hippocampus, and interoceptive pathways to generate a prediction about what the body will need. If the prediction is "threat is likely," cortisol is released preemptively. This is efficient when predictions are accurate and threats are transient. It becomes pathological when predictions are chronically pessimistic or when the environment offers no corrective feedback.

Chronic HPA activation, in this view, reflects a nervous system that has learned to predict danger even when danger is not present. The system is not malfunctioning; it is executing a model built from prior experience. This distinction is clinically significant. If the HPA axis is intelligent and predictive, then intervention must address the prediction itself, not merely the output. Suppressing cortisol without revising the underlying model is unlikely to produce durable change.

This is where the NIRVA Method becomes operationally relevant. The HPA axis implicates all six movements, but it is most directly engaged by **Identify** and **Regulate**. Identify involves recognizing the predictions the nervous system is making—often implicit, often learned early, often no longer contextually appropriate. A person who grew up in an unpredictable household may carry a prediction that safety is temporary and vigilance is necessary. That prediction will activate the HPA axis even in objectively safe environments. Identify names that prediction without judgment.

Regulate involves introducing new data that allows the nervous system to revise its model. This is not cognitive reframing. It is embodied: slow breathing, vagal tone enhancement, predictable routines, and safe relational contexts all provide bottom-up signals that threat is not imminent. Over time, these signals update the prediction, and HPA activation recalibrates. The system learns that it does not need to prepare for danger continuously.

The NSI framework also clarifies why HPA dysregulation is so often comorbid with mood, anxiety, and cognitive disorders. These are not separate diseases; they are expressions of a nervous system operating under a chronic prediction of threat. The HPA axis is one output of that prediction. Others include altered threat detection (amygdala hyperreactivity), impaired contextual memory (hippocampal dysfunction), and reduced reward sensitivity (ventral striatal blunting). Treating the HPA axis in isolation misses the larger architecture. The goal is to revise the prediction that drives all of these outputs.

For clinicians, recognizing HPA axis dysregulation requires moving beyond symptom checklists to physiological assessment. Salivary cortisol sampling—particularly the cortisol awakening response and diurnal slope—offers a noninvasive window into HPA function. Flattened diurnal rhythms, blunted awakening response, or elevated evening cortisol are all markers of dysregulation and may predict treatment resistance or relapse risk.

When HPA involvement is suspected, first-line interventions should target both the psychological and physiological layers. Cognitive-behavioral therapy, mindfulness-based interventions, and trauma-focused therapies have all demonstrated HPA-normalizing effects in controlled trials. These are not adjunctive; they are mechanistic. Pharmacotherapy may be necessary, particularly when depression or anxiety is severe, but SSRIs and SNRIs do not directly address HPA dysregulation and may require augmentation with interventions that restore circadian rhythm, sleep architecture, and autonomic balance.

Sleep is a particularly high-yield target. HPA axis activity is tightly coupled to the sleep-wake cycle, and chronic sleep disruption is both a cause and consequence of cortisol dysregulation. Cognitive-behavioral therapy for insomnia has been shown to normalize HPA function and should be considered a first-line intervention in patients with comorbid mood and sleep disturbance.

Clinicians should also assess for glucocorticoid receptor resistance, particularly in patients with elevated inflammatory markers despite normal or low cortisol. In these cases, anti-inflammatory interventions—dietary modification, exercise, omega-3 supplementation—may be more effective than cortisol-targeted strategies. The goal is not to suppress the HPA axis but to restore its sensitivity and flexibility.

Finally, clinicians must recognize that HPA dysregulation is often a marker of chronic unpredictability or lack of control. Interventions that restore a sense of agency—structured routines, collaborative goal-setting, autonomy-supportive therapy—address the prediction layer and may be as important as any biological intervention. The nervous system is responding to what it has learned. Clinical work involves helping it learn something new.

For individuals, working with HPA axis dysregulation begins with recognizing its somatic signatures: waking unrefreshed, difficulty winding down at night, frequent illness, weight gain around the midsection, brain fog, and a pervasive sense of being "wired and tired." These are not character flaws. They are outputs of a nervous system operating under sustained demand.

The most accessible intervention is rhythm. The HPA axis is circadian, and it responds to predictable structure. Waking and sleeping at consistent times, eating at regular intervals, and exposing yourself to bright light in the morning all provide temporal cues that help the system recalibrate. This is not about perfection. It is about reducing unpredictability.

Breathing practices that lengthen the exhale—four counts in, six counts out—activate the vagus nerve and signal safety to the brainstem. Done for five minutes twice daily, this practice has been shown to reduce cortisol and improve heart rate variability. It is not relaxation for its own sake; it is data that updates the nervous system's prediction.

Movement matters, but intensity matters more. High-intensity exercise can further activate the HPA axis if the system is already dysregulated. Walking, yoga, and resistance training at moderate intensity provide the benefits of movement without additional cortisol load. The goal is not exhaustion but embodied presence.

Social connection is underappreciated as an HPA regulator. Safe, predictable relationships provide co-regulatory signals that the nervous system cannot generate alone. This does not require deep disclosure. It requires presence: a conversation without agenda, a shared meal, a text exchange that expects nothing. The nervous system tracks these moments and uses them to revise its predictions about the world.

Finally, if you have been under chronic stress for months or years, do not expect rapid resolution. The HPA axis adapted slowly, and it will recalibrate slowly. The task is not to force recovery but to provide consistent, embodied signals that threat is not imminent. Over time, the system will learn.